Guangdong Jiaying Pharmaceutical (002198.SZ) main shareholder Orient completes reduction of 1% shareholding.
Jiaying Pharmaceutical (002198.SZ) announced that the company's shareholder Dongfang Securities, holding more than 5% of the company's shares, has cumulatively reduced its stake in the company by 5%.
Announcement from Guangdong Jiaying Pharmaceutical(002198.SZ): Shareholder Orient, holding more than 5% of the company's shares, has cumulatively reduced its stake by 5.075 million shares, accounting for 1.00% of the total share capital. The reduction plan has been successfully completed.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
